10-Q: NexPoint Capital Reports Q3 Net Investment Income Surge
Quarterly Report
NexPoint Capital, Inc. reported a significant increase in net investment income for the third quarter and first nine months of 2025, despite a decline in net assets and unrealized portfolio depreciation.
Summary
- Net investment income for the nine months ended September 30, 2025, significantly improved to $673,771, compared to a loss of $(78,642) in the prior year.
- For the three months ended September 30, 2025, net investment income was $164,133, a substantial improvement from a loss of $(113,157) in the same period last year.
- Total net assets decreased to $39,900,195 as of September 30, 2025, from $45,276,270 as of December 31, 2024.
- Net asset value per share declined to $4.73 from $5.21 over the same period.
- The company experienced a net decrease in net assets from operations of $(1,822,531) for the nine months ended September 30, 2025, contrasting with an increase of $3,278,659 in the prior year.
- This decrease was primarily driven by a significant net change in unrealized depreciation on investments of $(2,317,162) for the nine months ended September 30, 2025, compared to appreciation of $3,304,352 in the prior year.
- Total investment income increased to $1,676,779 for the nine months ended September 30, 2025, from $1,414,538 in the prior year.
- Operating expenses, net of Adviser waivers/recoupments, decreased to $1,043,432 for the nine months ended September 30, 2025, from $1,199,105 in the prior year.
- No new long or short investments were made during the nine months ended September 30, 2025, with proceeds from sales and principal repayments totaling $2,362,870.
- 91.1% of net assets ($36,361,244) were fair valued using the company's valuation procedures (Level 3) as of September 30, 2025, indicating a high proportion of illiquid assets.
- A $150,000 reversal of previously accrued preferred dividends, deemed uncollectible, was included in dividend income for the nine-month period ended September 30, 2025.
Sentiment
Score: 4
Explanation: The significant improvement in net investment income is a positive, but it is overshadowed by a substantial decline in net asset value per share and a large net change in unrealized depreciation on investments, leading to an overall decrease in net assets from operations. This suggests underlying issues with portfolio valuation and capital erosion despite better income generation.
Positives
- Net investment income significantly improved, turning from a loss in the prior year to positive income for both the three and nine months ended September 30, 2025.
- Total investment income increased for both the three-month ($478,206 vs. $418,608) and nine-month ($1,676,779 vs. $1,414,538) periods compared to the prior year.
- Net expenses decreased for both periods, partly due to the Adviser's fee waivers and reimbursements.
- The Adviser continues to be contractually obligated to waive fees and reimburse certain expenses to limit ordinary Other Expenses to 1.0% of gross assets, with the agreement continuing through at least April 30, 2026.
- The company's portfolio yield, prior to leverage costs, was 9.4% based on the amortized cost of investments as of September 30, 2025.
Negatives
- Total net assets decreased by over $5 million, from $45,276,270 at December 31, 2024, to $39,900,195 at September 30, 2025.
- Net asset value per share declined from $5.21 to $4.73 over the nine-month period.
- The company reported a net decrease in net assets from operations of $(1,822,531) for the nine months ended September 30, 2025, a significant reversal from a $3,278,659 increase in the prior year.
- A substantial net change in unrealized depreciation on investments of $(2,317,162) for the nine months ended September 30, 2025, indicates a decline in portfolio value.
- A $150,000 reversal of previously accrued preferred dividends, determined to be uncollectible, negatively impacted dividend income for the nine-month period.
- Cash and cash equivalents decreased from $1,671,503 at December 31, 2024, to $937,319 at September 30, 2025.
- The company incurred a net realized loss on affiliated investments of $(284,785) for the nine months ended September 30, 2025.
Risks
- Conflict of Interest Risk: The Adviser or its affiliates may have other clients with similar, different, or competing investment objectives, potentially leading to conflicts in investment opportunity allocation.
- Concentration Risk: The company is non-diversified and may hold large positions in a small number of issuers or concentrate investments in a few industries, making it susceptible to significant adverse effects from poor performance of a few investments or industry downturns.
- Covenant-Lite Loans Risk: Investments in covenant-lite loans carry more risk due to fewer or less restrictive covenants, potentially leading to greater difficulty or delays in enforcing rights.
- Counterparty Credit Risk: Potential loss from the failure of a counterparty or issuer to make payments, especially with over-the-counter derivatives.
- Credit Risk: Debt securities are subject to non-payment of interest/principal, particularly high-yield or junk debt, which are speculative. PIK interest loans defer payment obligations, increasing default risk.
- Foreign Securities Risk: Investments in foreign securities involve risks related to currency exchange, differences in markets, political/social/economic instability, and credit extension.
- Illiquid Securities Risk: Investments in private companies are largely illiquid, making them difficult to sell quickly and potentially leading to realizing significantly less than recorded value upon liquidation.
- Interest Rate Risk: Fixed income securities decline in value with rising interest rates; floating rate debt increases interest expense with rising rates, potentially reducing net investment income.
- Investments in Foreign Markets Risk: Special risks including currency revaluation, inflation, repatriation restrictions, political/economic developments, less liquid markets, and potential capital gains/repatriation taxes.
- Leverage Risk: Use of borrowed funds and certain options increases opportunity for higher returns but also increases risk of loss.
- Operational and Technology Risk: Cyber-attacks, disruptions, or failures affecting service providers, counterparties, or market participants may adversely affect the company.
- Options Risk: Risks associated with options transactions include imperfect correlation, market behavior, unexpected events, and potential for unlimited loss in uncovered short options.
- Real Estate Securities Risk: Securities of real estate issuers are subject to changes in real estate values, property taxes, overbuilding, rental income variations, interest rates, and regulatory changes.
- Real Estate Investment Trusts (REITs) Risk: Equity REITs are affected by underlying property values, mortgage REITs by credit quality; both are dependent on management skill, subject to cash flow dependency, defaults, and tax status qualification issues.
- Securities Market Risk: Value of securities may fluctuate rapidly due to factors affecting companies or markets generally, including economic, political, financial conditions, industry trends, and public health risks.
- Senior Loans Risk: Issuer may fail to pay interest/principal, and changes in market interest rates may reduce value or returns. Below investment grade senior loans are speculative.
- Structured Finance Securities Risk: Investments in instruments like CLOs bear credit risk of underlying collateral; junior tranches are highly sensitive to defaults.
- Short-Selling Risk: Short sales, especially uncovered, involve theoretically unlimited loss potential if market prices continuously increase, and can be exacerbated by short squeezes.
- Swaps Risk: Involves risks of underlying investments and counterparty risk; swaps can be leveraged, illiquid, and difficult to value, potentially leading to unexpected losses.
Future Outlook
The company's forward-looking statements indicate expectations regarding future operating results, changes in healthcare technologies and regulations, economic and market conditions, business prospects, impact of investments and competition, contractual arrangements, dependence on the general economy, portfolio company objectives, impact of COVID-19 or future pandemics, Adviser performance, financings and investments, ability to make distributions, adequacy of cash resources, use of financial leverage, Adviser's ability to locate and administer investments, ability to attract and retain professionals, maintenance of RIC and BDC qualifications, impact of Dodd-Frank Act, and changes to tax legislation. However, actual results could differ materially due to various risks and uncertainties.
Management Comments
- Management is of the opinion, based on the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of September 30, 2025.
- Management believes that the realization of the deferred tax assets is more likely than not based on expectations as to future taxable income and scheduled reversals of temporary differences.
Industry Context
The company operates as a Business Development Company (BDC) primarily investing in middle-market healthcare companies, non-healthcare sectors, syndicated floating rate debt, and CLOs. Its focus on healthcare and opportunistic investments aligns with a strategy to generate high current income and capital appreciation. The significant portion of illiquid, fair-valued assets (91.1% Level 3) is typical for BDCs investing in private middle-market companies, but also highlights inherent valuation challenges and liquidity constraints compared to publicly traded securities. The increase in net investment income, despite overall net asset decline, suggests some success in income generation from its debt-focused portfolio in a potentially higher interest rate environment (3-Month SOFR at 4.2% vs 4.3% previously).
Comparison to Industry Standards
- The company's investment strategy focuses on middle-market healthcare companies, which is a specialized niche within the BDC space. Direct comparisons are challenging without specific peer data in the filing.
- The high percentage of Level 3 fair-valued assets (91.1% of net assets) is common for BDCs that invest in private, illiquid debt and equity, such as those held by Ares Capital Corporation or Golub Capital BDC, Inc., which also report significant portions of their portfolios in Level 3. However, this also implies higher valuation subjectivity compared to BDCs with more liquid, publicly traded holdings.
- The estimated gross annual portfolio yield of 9.4% is competitive within the BDC sector, where yields often range from 8% to 12% depending on the risk profile and leverage. For example, Main Street Capital (MAIN) often reports yields in a similar range for its debt investments.
- The decline in NAV per share from $5.21 to $4.73 is a concern and would be compared against the NAV performance of other BDCs over the same period. Many BDCs experienced some NAV volatility due to market conditions and credit quality changes.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Designation | The Board has designated the Adviser as valuation designee for the Company pursuant to Rule 2a-5 of the 1940 Act. | NA | Enhances the Adviser's role in determining fair value of securities, subject to Board oversight. |
| Accounting Standard Adoption | Adopted FASB Accounting Standards Update (ASU) 2023-07 Segment Reporting, resulting in new financial statement disclosures. | January 1, 2025 | Improved transparency in segment reporting, but no direct impact on financial position or results of operations. |
| Agreement Amendment | Investment Advisory Agreement and Administration Agreement amended to exclude cash and cash equivalents from the calculation of gross assets for fee purposes. | June 5, 2017 | Potentially reduces the base management and administration fees payable to the Adviser by narrowing the asset base for calculation. |
| Policy Change | Adviser ended its voluntary waiver of advisory and administration fees. | December 20, 2017 | Increased the fees paid to the Adviser, potentially impacting net investment income, though subject to the Expense Limitation Agreement. |
| Distribution Schedule Change | Board approved a change in its dividend and capital gains distribution schedule from monthly to quarterly. | June 24, 2020 | Altered the frequency of distributions to shareholders from monthly to quarterly. |
Legal Proceedings
- The company is currently not a party to any pending material legal proceedings, although it may be involved in litigation in the normal course of business.
Related Party Transactions
- The company has an Investment Advisory Agreement with NexPoint Advisors, L.P. (the Adviser), which is controlled by James Dondero, the company's president.
- An Administration Agreement is in place with the Adviser for office facilities and administrative services.
- The Expense Limitation Agreement obligates the Adviser to waive fees or reimburse expenses to limit ordinary Other Expenses to 1.0% of gross assets, with a cumulative recoupable amount of $1,391,221 as of September 30, 2025.
- NexPoint Securities, Inc., the dealer manager, is an affiliate of the Adviser.
- Liberty CLO Holdco Ltd. (Liberty) purchased 2,549,002 shares of common stock from the Adviser on July 21, 2023, and now controls 30.2% of the company's currently issued and outstanding common stock.
- The Adviser has committed $2,275,000 cumulatively since inception to voluntarily reimburse the company for unrealized losses, which are non-recoupable.
- As of September 30, 2025, $140,805 was owed from the Adviser to the company, largely related to the expense limitation agreement.
- As of September 30, 2025, the company owed $218,871 to the Adviser, largely related to advisory and administration fees.
- The Adviser and its affiliates manage other investment funds/accounts with similar mandates, leading to potential conflicts of interest in investment allocation, managed by an allocation policy and co-investment relief.
Stakeholder Impact
- Shareholders: Experienced a decline in Net Asset Value per share from $5.21 to $4.73. Distributions are ongoing quarterly, but a portion may be deemed return of capital for tax purposes. The share repurchase program offers some liquidity.
- Adviser: Continues to receive management and administration fees. Subject to expense limitation agreement and has made non-recoupable reimbursements for unrealized losses.
- Portfolio Companies: Benefit from the company's investments, primarily senior secured loans and equity.
- Creditors: The company has no unfunded debt commitments as of September 30, 2025, indicating a stable debt position.
Next Steps
- Continue to manage investments to generate current income and capital appreciation.
- Adviser will continue to perform fair valuation determination for securities and other assets held by the company.
- The Expense Limitation Agreement will continue through at least April 30, 2026.
- The company intends to offer to repurchase shares of common stock on a quarterly basis, subject to Board discretion and limitations.
- The company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis.
- The company intends to distribute any realized net capital gains at least annually to maintain RIC status.
Key Dates
| Date | Description |
|---|---|
| September 30, 2013 | Company formed in Delaware. |
| September 2, 2014 | Company formally commenced operations and Investment Advisory Agreement became effective. |
| March 2, 2016 | Custodian Agreement and Expense Limitation Agreement incorporated by reference. |
| June 5, 2017 | Investment Advisory Agreement and Administration Agreement amended to exclude cash and cash equivalents from fee calculation. |
| May 11, 2017 | Forms of Subscription Agreement filed. |
| September 30, 2017 | Amended and Restated Investment Advisory Agreement and Administration Agreement incorporated by reference. |
| December 20, 2017 | Adviser ended its voluntary waiver of advisory, incentive, and administration fees. |
| February 14, 2018 | Company's continuous public offering ended. |
| June 24, 2020 | Board approved change in dividend and capital gains distribution schedule from monthly to quarterly. |
| October 12, 2020 | First quarterly distribution paid. |
| March 31, 2022 | Recoupment eligibility for Q1 2022 expense reimbursements expired. |
| June 30, 2022 | Recoupment eligibility for Q2 2022 expense reimbursements expired. |
| September 30, 2022 | Recoupment eligibility for Q3 2022 expense reimbursements expired. |
| December 31, 2022 | Recoupment eligibility for Q4 2022 expense reimbursements expires. |
| March 31, 2023 | Recoupment eligibility for Q1 2023 expense reimbursements expires. |
| June 21, 2023 | BDC Sapience Holdco, LLC formed. |
| June 30, 2023 | Recoupment eligibility for Q2 2023 expense reimbursements expires. |
| July 21, 2023 | Liberty CLO Holdco Ltd. purchased 2,549,002 shares of common stock from the Adviser. |
| September 30, 2023 | Recoupment eligibility for Q3 2023 expense reimbursements expires. |
| December 31, 2023 | Recoupment eligibility for Q4 2023 expense reimbursements expires. |
| March 15, 2024 | BDC US Gaming Holdco, LLC and BDC AB Holdco, LLC formed. |
| March 31, 2024 | Recoupment eligibility for Q1 2024 expense reimbursements expires. |
| June 30, 2024 | Recoupment eligibility for Q2 2024 expense reimbursements expires. |
| September 30, 2024 | End of prior year comparable nine-month period; Recoupment eligibility for Q3 2024 expense reimbursements expires. |
| December 31, 2024 | End of prior fiscal year; Recoupment eligibility for Q4 2024 expense reimbursements expires. |
| January 1, 2025 | Adopted FASB Accounting Standards Update (ASU) 2023-07 Segment Reporting. |
| February 21, 2025 | Start of quarterly tender offer for the first quarter of 2025. |
| March 24, 2025 | End of quarterly tender offer for the first quarter of 2025. |
| March 31, 2025 | Recoupment eligibility for Q1 2025 expense reimbursements expires. |
| May 16, 2025 | Start of quarterly tender offer for the second quarter of 2025. |
| June 17, 2025 | End of quarterly tender offer for the second quarter of 2025. |
| June 30, 2025 | Recoupment eligibility for Q2 2025 expense reimbursements expires. |
| August 15, 2025 | Start of quarterly tender offer for the third quarter of 2025. |
| September 16, 2025 | End of quarterly tender offer for the third quarter of 2025. |
| September 30, 2025 | End of current reporting period; Recoupment eligibility for Q3 2025 expense reimbursements expires. |
| November 14, 2025 | Date of filing of the Quarterly Report on Form 10-Q. |
| April 30, 2026 | Expense Limitation Agreement continues through at least this date. |
Recommendation
holdWhile the company demonstrated a strong turnaround in net investment income, indicating effective income generation from its portfolio, the substantial decline in Net Asset Value per share and significant unrealized depreciation on investments are concerning. The high proportion of Level 3 fair-valued assets introduces valuation subjectivity and liquidity risk. The ongoing expense reimbursements from the Adviser are positive, but the overall erosion of net assets from operations suggests underlying portfolio challenges. A 'hold' recommendation is appropriate as investors should monitor whether the improved net investment income can stabilize or reverse the trend of NAV decline and unrealized losses in future periods. The current performance presents a mixed picture, warranting caution rather than a strong buy or sell.
Keywords
Business Development Company, BDC, SEC Filing, 10-Q, Investment Company Act of 1940, Regulated Investment Company, RIC, Fair Value Measurement, Senior Secured Loans, Corporate Bonds, Common Stocks, LLC Interests, Preferred Stocks, Healthcare Investments, Telecommunication Services, Real Estate Investments, Financial Performance, Net Asset Value, Investment Income, Unrealized Depreciation, Expense Limitation Agreement, Related Party Transactions, Portfolio Management, Credit Risk, Liquidity Risk, Interest Rate Risk, Share Repurchase Program
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.